CES 2017: Center Stage for the 5G Revolution
20.12.2016 22:08 | Business Wire
CES® 2017 is the world’s largest show for connectivity. The entire global technology ecosystem will gather to showcase the revolutionary impact 5G, the next generation of mobile network technology, will have on connectivity and mobility across every major business sector. The future of 5G and its effect on the connected world will be a major focus at CES 2017, highlighted by the SuperSession, “Stoked About 5G,” presented by Ericsson. Owned and produced by the Consumer Technology Association (CTA)TM, CES 2017 is scheduled January 5-8, in Las Vegas, Nevada.
“From the Internet of Things, to virtual reality to self-driving cars and beyond, connectivity is at the core of emerging innovation. With the entire spectrum of technology on display, there is no better place to experience the 5G revolution than at CES 2017,” said Gary Shapiro, president and CEO, CTA. “Ericsson’s SuperSession will paint a picture of our new connected world with 5G technology, including new products and services that will revolutionize the way consumers live, work and play. With more than 3,800 exhibiting companies across 24 product categories, the true impact of connectivity will be unveiled at CES 2017.”
The “Stoked About 5G” SuperSession presented by Ericsson will take place at 10:15 AM, Thursday, January 5 in the LVCC, North Hall, Room N257. The session will explore the bright future of mobility with 5G, the network that reacts faster than the human brain. Speakers include:
- Hanno Basse, CTO, 20th Century Fox Film Corp.
- Alex Choi, CTO, EVP and Head of Corporate R&D Center, SK Telecom
- Dr. Fathi El-Dwaik, Vice President, Information and Communication Electronics, BMW Group
- Ulf Ewaldsson, Sr. VP, Chief Strategy and Technology Officer, Ericsson Inc.
- Ina Fried, Senior Editor, Re/code (Moderator)
Connectivity will be ubiquitous throughout CES 2017, touching nearly every product category from automotive to smart home, robotics, fitness tech, health and wellness, wearables and more. In addition, the CES Conference Program will highlight the latest developments in connected mobility with topics including Self Driving Technology, IoT, Smart Cities, Digital Health and 5G, as well as a keynote from Qualcomm CEO Steve Mollenkopf, who will discuss the worldwide impact of 5G.
In addition to Ericsson, leaders in connectivity and mobility will be at CES launching new products and services such as: Huawei, Qualcomm, Sprint, Verizon, Samsung, LG, TCL, ZTE Blackberry, Nokia and more. 5G will open up an explosion of new services – including broadband and better home services, faster connectivity for smart cars, affordable smart city infrastructure and interactive AR/VR experiences. With the full spectrum of technology on display, CES 2017 will illustrate how 5G will truly benefit consumers.
Visit CES.tech for the latest news and announcements or to register for CES 2017.
Note to Editors: The official name of the global technology event is “CES ® .” Please do not use “Consumer Electronics Show” or “International CES” to refer to the event.
CES is the world’s gathering place for all who thrive on the business of consumer technologies. It has served as the proving ground for innovators and breakthrough technologies for 50 years—the global stage where next-generation innovations are introduced to the marketplace. As the largest hands-on event of its kind, CES features all aspects of the industry. Owned and produced by the Consumer Technology Association (CTA)TM, it attracts the world’s business leaders and pioneering thinkers. Check out CES video highlights. Follow CES online at CES.tech and on social.
About Consumer Technology Association:
Consumer Technology Association (CTA)TM, is the trade association representing the $287 billion U.S. consumer technology industry. More than 2,200 companies – 80 percent are small businesses and startups; others are among the world’s best known brands – enjoy the benefits of CTA membership including policy advocacy, market research, technical education, industry promotion, standards development and the fostering of business and strategic relationships. The Consumer Technology Association also owns and produces CES® – the world’s gathering place for all who thrive on the business of consumer technologies. Profits from CES are reinvested into CTA’s industry services.
CES Unveiled Las Vegas
January 3, Las Vegas, NV
CES 2017 –
January 5-8, Las Vegas, NV
March 9-12, Snowmass, CO
Digital Patriots Dinner
April 4, Washington, DC
CES on the Hill
April 5, Washington, DC
CES Asia 2017
June 7-9, Shanghai, China
June 21-24, Amalfi Coast, Italy
Om Business Wire
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
European Commission Grants New Indication for Soliris® (Eculizumab) for the Treatment of Patients with Refractory Generalized Myasthenia Gravis (gMG)21.8.2017 13:25 | Pressemelding
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that the European Commission (EC) approved the extension of the indication for Soliris® (eculizumab) to include the treatment of refractory generalized myasthenia gravis (gMG) in adults who are anti-acetylcholine receptor (AChR) antibody-positive. Soliris is the first and only complement-based therapy approved in the European Union (EU) for this ultra-rare subset of patients.1-4 Patients with refractory gMG can have difficulties walking, talking, swallowing and breathing normally despite therapies currently used for MG. Exacerbations and crises of their disease may require hospitalization and intensive care and may be life-threatening.5-7 Soliris will be launched for this new indication initially in Germany, and Alexion is evaluating launches in additional EU countries. “Patients with refractory gMG have exhausted multiple the
IntegenX Applauds the Passage of the Rapid DNA Act of 201721.8.2017 12:00 | Pressemelding
IntegenX Inc., the global market leader for Rapid DNA human identification, applauds the signing into law of S.139 and HR.510, The Rapid DNA Act of 2017. The legislation will allow law enforcement agencies, under standards and guidelines established by the FBI, to perform real-time DNA testing at time of arrest, within booking stations. Similar to how fingerprint analysis has evolved from a paper and ink practice to a point-of-action technology, DNA testing has now become possible in 90 minutes within a booking station, while a suspect is still in custody. With processing times reduced from weeks to less than two hours, the potential to identify or exonerate a suspect quickly will make a meaningful impact on law enforcement. IntegenX thanks U.S. Senate sponsor Senator Orrin Hatch (R-UT) and lead co-sponsor Senator Dianne Feinstein (D-CA) as well as House sponsor Congressman
PPG Completes COLORFUL COMMUNITIES Project at Primary School in Kecskemét, Hungary21.8.2017 08:03 | Pressemelding
PPG (NYSE:PPG) today announced the completion of a COLORFUL COMMUNITIES™ project in Kecskemét, Hungary, that helped revitalize the learning environment of the Corvin Mátyás primary school. The Colorful Communities program provides PPG volunteers and products along with financial contributions to bring color and vitality to communities where the company operates around the world, such as in Kecskemét, where the PPG automotive service team operates with 33 employees. The project brought together more than 140 PPG and community volunteers who spent three days at the school revitalizing four classrooms, four changing rooms and the playground. PPG provided more than $20,000 to assist with the project, including more than 460 liters of Héra ® Prémium waterborne interior paint and Trinát ® Aqua wate
Glennmont Partners Completes Refinancing of Sleaford Biomass Plant for £150m21.8.2017 08:00 | Pressemelding
Glennmont Partners has successfully completed the refinancing of the Sleaford Renewable Energy Plant on behalf of its dedicated clean energy fund, Glennmont Clean Energy Fund Europe I, as part of a programme of realisations of value from the Fund. Glennmont Partners is one of Europe’s largest fund managers focusing exclusively on investment in clean energy infrastructure. Glennmont raises long-term capital to invest in alternative power generation projects including wind farms, biomass power stations, solar parks and small-scale hydro power plants. The carefully selected, risk managed investments deliver sustained performance and predictable returns over periods of 10 years or more. Sleaford REP is a 40MWe straw-fired biomass plant located in Lincolnshire, UK. The plant has been in operation since 2014 and is being operated by Burmeister & Wain Scandinavian Contractor (BWSC). The
Boehringer Ingelheim: Advancing anticoagulation care with new data at ESC Congress 201721.8.2017 07:08 | Pressemelding
Boehringer Ingelheim today announced that it will present important new data on the treatment of patients with atrial fibrillation (AF) at the ESC Congress in Barcelona, Spain, 26-30 August 2017. In total, four abstracts have been accepted, investigating different aspects of AF patient treatment. The results of the RE-DUAL PCI™ trial have been selected for one of the Late Breaking Science sessions of the congress. The RE-DUAL PCI™ trial compared dual therapy with triple therapy after percutaneous coronary intervention (PCI) with stent placement in approximately 2,500 adults with atrial fibrillation. Patients were either treated with dabigatran etexilate (Pradaxa®) and a single antiplatelet agent or with the vitamin K antagonist (VKA) warfarin and two antiplatelets. The dabigatran doses investigated in this trial are the same doses which have already demonstrated effective stroke preven
Study Investigates Performance of Masimo PVi® As Part of Goal-Directed Fluid Therapy During Laparoscopic Bariatric Surgery21.8.2017 06:00 | Pressemelding
Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers at Firat University in Turkey evaluated the performance of Masimo PVi®, a noninvasive and continuous measurement of the dynamic changes in perfusion index (Pi) that occur during respiratory cycles, as the basis of a goal-directed fluid therapy (GDFT) protocol during laparoscopic bariatric surgery on mechanically-ventilated patients.1 In the study, Dr. Demirel and colleagues sought to evaluate whether using GDFT guided by PVi on morbidly obese patients undergoing laparoscopic Roux-en-Y gastric bypass (RYGB) surgery might result in less intravenous fluid use without compromising outcomes. They enrolled 60 patients and divided them randomly into control and GDFT groups. The control group’s fluid levels were managed by standard fluid therapy, using mean arterial pressure (MAP) and
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom